Tapewire

Nasdaq · USD

VRCA

Verrica Pharmaceuticals Inc.

Export transactions ↓
Tapewire entity
6823
SEC CIK
0001660334
Parsed reports
253

Last 12 months

Inside the activity.

12 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202560
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202660
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
November 22, 2024 Filed Nov 26, 2024 21:15 UTC
Manning Paul BDirector · 10% owner
PurchaseCommon Stock 18,426,966 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-24-027709 · form4-11262024_041101.xml · nonDerivative · entry 1

Manning Paul B · CIK 0001494695 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,278,094

F1 · price: The reported securities are included within 18,426,966 investment units purchased by the Reporting Person for $0.89 per investment unit. Each investment unit consists of one share of Common Stock,a Series A warrant for one half of a share of common stock and a Series B warrant for one half of a share of common stock. The Reporting Person will not be entitled to exercise any portion of a Series A or Series B Warrant that, upon giving effect to such exercise, would cause the aggregate number of shares beneficially owned by the Reporting Person to exceed 49.99% of the number of shares of the Issuer's common stock outstanding immediately after giving effect to the exercise.

F2 · ownership.direct: The shares are held by Mr. Manning jointly with his spouse.

Read SEC document
November 06, 2024 Filed Nov 7, 2024 02:02 UTC
Rieger JaysonDirector · CEO and President
GrantEmployee Stock Option (right to buy) · Derivative 2,000,000 $0.00 Strike: $0.75 $0.00
Disclosure

SEC source: 0001415889-24-026286 · form4-11072024_021140.xml · derivative · entry 1

Rieger Jayson · CIK 0002043558 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,000,000

Underlying: Common Stock · 2,000,000 shares

Expires 2034-11-06

F1 · derivative.exercise_date: 1/8th of the total shares subject to the option shall vest on May 5, 2025, and 1/48th of the total shares subject to the option shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continuous service through such vesting date.

Read SEC document
November 06, 2024 Filed Nov 7, 2024 02:04 UTC
Kirby John J.Interim CFO
GrantCommon Stock 54,267 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-026290 · form4-11072024_021129.xml · nonDerivative · entry 1

Kirby John J. · CIK 0001556327 · Interim CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,267

F1 · shares: Represents a restricted stock unit ("RSU") award. The RSUs shall vest vest in full on May 4, 2025, subject to the Reporting Person's continuous service through such date.

Read SEC document
October 09, 2024 Filed Oct 11, 2024 16:15 UTC
Hayes Christopher G.CHIEF LEGAL OFFICER
GrantEmployee Stock Option (right to buy) · Derivative 50,000 $0.00 Strike: $1.28 $0.00
Disclosure

SEC source: 0001415889-24-025026 · form4-10112024_041004.xml · derivative · entry 1

Hayes Christopher G. · CIK 0001805359 · CHIEF LEGAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2034-10-09

F1 · derivative.exercise_date: 50% of the total shares subject to the option shall vest on each of April 9, 2025 and October 9, 2025, subject to the Reporting Person's continuous service through such vesting date.

Read SEC document
September 19, 2024 Filed Sep 23, 2024 20:15 UTC
Manning Paul BDirector · 10% owner
GiftCommon Stock 891,870.42 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-023835 · form4-09232024_040901.xml · nonDerivative · entry 4

Manning Paul B · CIK 0001494695 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By trust

Disclosed balance after: 891,870.42

F1 · kind: Upon termination of a Grantor Retained Annuity Trust, 2,675,611.25 shares were transferred to trusts for the benefit of the Reporting Person's immediate family members on September 19, 2024.

F2 · ownership.nature: These shares are held in separate trusts for the benefit of the Reporting Person's immediate family members. The Reporting Person's spouse is trustee of each trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
September 19, 2024 Filed Sep 23, 2024 20:15 UTC
Manning Paul BDirector · 10% owner
GiftCommon Stock 891,870.42 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-023835 · form4-09232024_040901.xml · nonDerivative · entry 3

Manning Paul B · CIK 0001494695 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By trust

Disclosed balance after: 891,870.42

F1 · kind: Upon termination of a Grantor Retained Annuity Trust, 2,675,611.25 shares were transferred to trusts for the benefit of the Reporting Person's immediate family members on September 19, 2024.

F2 · ownership.nature: These shares are held in separate trusts for the benefit of the Reporting Person's immediate family members. The Reporting Person's spouse is trustee of each trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
September 19, 2024 Filed Sep 23, 2024 20:15 UTC
Manning Paul BDirector · 10% owner
GiftCommon Stock 891,870.41 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-023835 · form4-09232024_040901.xml · nonDerivative · entry 2

Manning Paul B · CIK 0001494695 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By trust

Disclosed balance after: 891,870.41

F1 · kind: Upon termination of a Grantor Retained Annuity Trust, 2,675,611.25 shares were transferred to trusts for the benefit of the Reporting Person's immediate family members on September 19, 2024.

F2 · ownership.nature: These shares are held in separate trusts for the benefit of the Reporting Person's immediate family members. The Reporting Person's spouse is trustee of each trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
September 19, 2024 Filed Sep 23, 2024 20:15 UTC
Manning Paul BDirector · 10% owner
GiftCommon Stock 2,675,611.25 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-023835 · form4-09232024_040901.xml · nonDerivative · entry 1

Manning Paul B · CIK 0001494695 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By GRAT

Disclosed balance after: 0

F1 · kind: Upon termination of a Grantor Retained Annuity Trust, 2,675,611.25 shares were transferred to trusts for the benefit of the Reporting Person's immediate family members on September 19, 2024.

Read SEC document
August 27, 2024 Filed Aug 28, 2024 20:15 UTC
Kohler TerryCHIEF FINANCIAL OFFICER
SaleCommon Stock 7,899 $2.46 $19,431.54
Disclosure

SEC source: 0001415889-24-022424 · form4-08282024_040804.xml · nonDerivative · entry 2

Kohler Terry · CIK 0001872285 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,697

F1 · kind: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the settlement of the restricted stock units. This sale was mandated by the Issuer's election under its 2018 equity incentive plan to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.40 to $2.53 inclusive.

Read SEC document
August 27, 2024 Filed Aug 28, 2024 16:15 UTC
Hayes Christopher G.CHIEF LEGAL OFFICER
SaleCommon Stock 9,530 $2.46 $23,443.80
Disclosure

SEC source: 0001415889-24-022427 · form4-08282024_040809.xml · nonDerivative · entry 2

Hayes Christopher G. · CIK 0001805359 · CHIEF LEGAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 105,773

F1 · kind: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the settlement of the restricted stock units. This sale was mandated by the Issuer's election under its 2018 equity incentive plan to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.40 to $2.53 inclusive.

Read SEC document
August 27, 2024 Filed Aug 28, 2024 20:15 UTC
Goldenberg GaryChief Medical Officer
SaleCommon Stock 3,601 $2.46 $8,858.46
Disclosure

SEC source: 0001415889-24-022426 · form4-08282024_040807.xml · nonDerivative · entry 2

Goldenberg Gary · CIK 0001741938 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,261

F1 · kind: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the settlement of the restricted stock units. This sale was mandated by the Issuer's election under its 2018 equity incentive plan to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.40 to $2.53 inclusive.

Read SEC document
August 27, 2024 Filed Aug 28, 2024 20:15 UTC
Bonaccorso JoeCHIEF COMMERCIAL OFFICER
SaleCommon Stock 8,993 $2.46 $22,122.78
Disclosure

SEC source: 0001415889-24-022425 · form4-08282024_040805.xml · nonDerivative · entry 2

Bonaccorso Joe · CIK 0001741973 · CHIEF COMMERCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,114

F1 · kind: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the settlement of the restricted stock units. This sale was mandated by the Issuer's election under its 2018 equity incentive plan to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.40 to $2.53 inclusive.

Read SEC document
August 27, 2024 Filed Aug 28, 2024 20:15 UTC
White TedDirector · PRESIDENT AND CEO
SaleCommon Stock 9,021 $2.46 $22,191.66
Disclosure

SEC source: 0001415889-24-022423 · form4-08282024_040801.xml · nonDerivative · entry 2

White Ted · CIK 0001741964 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 215,967

F1 · kind: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the settlement of the restricted stock units. This sale was mandated by the Issuer's election under its 2018 equity incentive plan to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.40 to $2.53 inclusive.

Read SEC document
August 26, 2024 Filed Aug 28, 2024 20:15 UTC
Kohler TerryCHIEF FINANCIAL OFFICER
SaleCommon Stock 21,820 $2.66 $58,041.20
Disclosure

SEC source: 0001415889-24-022424 · form4-08282024_040804.xml · nonDerivative · entry 1

Kohler Terry · CIK 0001872285 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,596

F1 · kind: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the settlement of the restricted stock units. This sale was mandated by the Issuer's election under its 2018 equity incentive plan to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.53 to $2.83 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3).

Read SEC document
August 26, 2024 Filed Aug 28, 2024 16:15 UTC
Hayes Christopher G.CHIEF LEGAL OFFICER
SaleCommon Stock 26,183 $2.66 $69,646.78
Disclosure

SEC source: 0001415889-24-022427 · form4-08282024_040809.xml · nonDerivative · entry 1

Hayes Christopher G. · CIK 0001805359 · CHIEF LEGAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 115,303

F1 · kind: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the settlement of the restricted stock units. This sale was mandated by the Issuer's election under its 2018 equity incentive plan to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.53 to $2.83 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3).

Read SEC document
August 26, 2024 Filed Aug 28, 2024 20:15 UTC
Goldenberg GaryChief Medical Officer
SaleCommon Stock 9,888 $2.66 $26,302.08
Disclosure

SEC source: 0001415889-24-022426 · form4-08282024_040807.xml · nonDerivative · entry 1

Goldenberg Gary · CIK 0001741938 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,862

F1 · kind: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the settlement of the restricted stock units. This sale was mandated by the Issuer's election under its 2018 equity incentive plan to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.53 to $2.83 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3).

Read SEC document
August 26, 2024 Filed Aug 28, 2024 20:15 UTC
Bonaccorso JoeCHIEF COMMERCIAL OFFICER
SaleCommon Stock 24,709 $2.66 $65,725.94
Disclosure

SEC source: 0001415889-24-022425 · form4-08282024_040805.xml · nonDerivative · entry 1

Bonaccorso Joe · CIK 0001741973 · CHIEF COMMERCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 82,107

F1 · kind: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the settlement of the restricted stock units. This sale was mandated by the Issuer's election under its 2018 equity incentive plan to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.53 to $2.83 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3).

Read SEC document
August 26, 2024 Filed Aug 28, 2024 20:15 UTC
White TedDirector · PRESIDENT AND CEO
SaleCommon Stock 24,979 $2.66 $66,444.14
Disclosure

SEC source: 0001415889-24-022423 · form4-08282024_040801.xml · nonDerivative · entry 1

White Ted · CIK 0001741964 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 224,988

F1 · kind: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the settlement of the restricted stock units. This sale was mandated by the Issuer's election under its 2018 equity incentive plan to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.53 to $2.83 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3).

Read SEC document
July 23, 2024 Filed Jul 23, 2024 18:10 UTC
Hayes Christopher G.CHIEF LEGAL OFFICER
SaleCommon Stock 91 $6.98 $635.18
Disclosure

SEC source: 0001415889-24-019970 · form4-07232024_100729.xml · nonDerivative · entry 2

Hayes Christopher G. · CIK 0001805359 · CHIEF LEGAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 141,486

F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the settlement of the restricted stock units. This sale was mandated by the Issuer's election under its 2018 equity incentive plan to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

Read SEC document
July 23, 2024 Filed Jul 23, 2024 22:13 UTC
White TedDirector · PRESIDENT AND CEO
SaleCommon Stock 154 $6.98 $1,074.92
Disclosure

SEC source: 0001415889-24-019976 · form4-07232024_100700.xml · nonDerivative · entry 2

White Ted · CIK 0001741964 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 249,967

F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the settlement of the restricted stock units. This sale was mandated by the Issuer's election under its 2018 equity incentive plan to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

Read SEC document
July 23, 2024 Filed Jul 23, 2024 22:12 UTC
Bonaccorso JoeCHIEF COMMERCIAL OFFICER
SaleCommon Stock 115 $6.98 $802.70
Disclosure

SEC source: 0001415889-24-019974 · form4-07232024_100716.xml · nonDerivative · entry 2

Bonaccorso Joe · CIK 0001741973 · CHIEF COMMERCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 106,816

F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the settlement of the restricted stock units. This sale was mandated by the Issuer's election under its 2018 equity incentive plan to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

Read SEC document
July 23, 2024 Filed Jul 23, 2024 22:11 UTC
Goldenberg GaryChief Medical Officer
SaleCommon Stock 86 $6.98 $600.28
Disclosure

SEC source: 0001415889-24-019972 · form4-07232024_100729.xml · nonDerivative · entry 2

Goldenberg Gary · CIK 0001741938 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 107,750

F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the settlement of the restricted stock units. This sale was mandated by the Issuer's election under its 2018 equity incentive plan to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

Read SEC document
July 22, 2024 Filed Jul 23, 2024 18:10 UTC
Hayes Christopher G.CHIEF LEGAL OFFICER
SaleCommon Stock 21,649 $7.06 $152,841.94
Disclosure

SEC source: 0001415889-24-019970 · form4-07232024_100729.xml · nonDerivative · entry 1

Hayes Christopher G. · CIK 0001805359 · CHIEF LEGAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 141,577

F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the settlement of the restricted stock units. This sale was mandated by the Issuer's election under its 2018 equity incentive plan to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.00 to $7.17 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
July 22, 2024 Filed Jul 23, 2024 22:13 UTC
White TedDirector · PRESIDENT AND CEO
SaleCommon Stock 32,469 $7.06 $229,231.14
Disclosure

SEC source: 0001415889-24-019976 · form4-07232024_100700.xml · nonDerivative · entry 1

White Ted · CIK 0001741964 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250,121

F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the settlement of the restricted stock units. This sale was mandated by the Issuer's election under its 2018 equity incentive plan to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.00 to $7.17 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
July 22, 2024 Filed Jul 23, 2024 22:12 UTC
Bonaccorso JoeCHIEF COMMERCIAL OFFICER
SaleCommon Stock 25,461 $7.06 $179,754.66
Disclosure

SEC source: 0001415889-24-019974 · form4-07232024_100716.xml · nonDerivative · entry 1

Bonaccorso Joe · CIK 0001741973 · CHIEF COMMERCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 106,931

F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the settlement of the restricted stock units. This sale was mandated by the Issuer's election under its 2018 equity incentive plan to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.00 to $7.17 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
July 22, 2024 Filed Jul 23, 2024 22:11 UTC
Goldenberg GaryChief Medical Officer
SaleCommon Stock 18,421 $7.06 $130,052.26
Disclosure

SEC source: 0001415889-24-019972 · form4-07232024_100729.xml · nonDerivative · entry 1

Goldenberg Gary · CIK 0001741938 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 107,836

F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the settlement of the restricted stock units. This sale was mandated by the Issuer's election under its 2018 equity incentive plan to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.00 to $7.17 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 06, 2024 Filed Jun 7, 2024 20:15 UTC
Nguyen DiemDirector
GrantStock Option (right to buy) · Derivative 20,000 $0.00 Strike: $8.78 $0.00
Disclosure

SEC source: 0001415889-24-015960 · form4-06072024_040611.xml · derivative · entry 1

Nguyen Diem · CIK 0001814338 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2034-06-05

F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 6, 2024 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director though the applicable vesting date.

Read SEC document
June 06, 2024 Filed Jun 7, 2024 20:15 UTC GrantStock Option (right to buy) · Derivative 20,000 $0.00 Strike: $8.78 $0.00
Disclosure

SEC source: 0001415889-24-015961 · form4-06072024_040613.xml · derivative · entry 1

PRYGOCKI MARK A SR · CIK 0001257544 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2034-06-05

F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 6, 2024 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director though the applicable vesting date.

Read SEC document
June 06, 2024 Filed Jun 7, 2024 20:15 UTC GrantStock Option (right to buy) · Derivative 20,000 $0.00 Strike: $8.78 $0.00
Disclosure

SEC source: 0001415889-24-015959 · form4-06072024_040609.xml · derivative · entry 1

Eichenfield Lawrence · CIK 0001814892 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2034-06-05

F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 6, 2024 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director though the applicable vesting date.

Read SEC document
June 06, 2024 Filed Jun 7, 2024 20:15 UTC GrantStock Option (right to buy) · Derivative 20,000 $0.00 Strike: $8.78 $0.00
Disclosure

SEC source: 0001415889-24-015958 · form4-06072024_040607.xml · derivative · entry 1

Ballaron Craig · CIK 0001779433 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2034-06-05

F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 6, 2024 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director though the applicable vesting date.

Read SEC document
March 15, 2024 Filed Mar 19, 2024 20:31 UTC
Kohler TerryCHIEF FINANCIAL OFFICER
GrantEmployee Stock Option (right to buy) · Derivative 80,000 $0.00 Strike: $4.80 $0.00
Disclosure

SEC source: 0001415889-24-008541 · form4-03192024_040349.xml · derivative · entry 2

Kohler Terry · CIK 0001872285 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires 2034-03-15

F2 · derivative.exercise_date: 25% of the total shares subject to the option shall vest on March 15, 2025 and 1/48th of the total shares subject to the option shall vest monthly thereafter over the remaining three years of the vesting period, subject to the Reporting Person's continuous service through such vesting date.

Read SEC document
March 15, 2024 Filed Mar 19, 2024 20:31 UTC
Kohler TerryCHIEF FINANCIAL OFFICER
GrantCommon Stock 40,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-008541 · form4-03192024_040349.xml · nonDerivative · entry 1

Kohler Terry · CIK 0001872285 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,416

F1 · shares: Represents a restricted stock unit ("RSU") award. The RSUs shall vest in equal annual installments on March 15, 2025, March 15, 2026, March 15, 2027 and March 15, 2028 subject to the Reporting Person's continuous service through each applicable date.

Read SEC document
March 15, 2024 Filed Mar 19, 2024 16:31 UTC
Hayes Christopher G.CHIEF LEGAL OFFICER
GrantEmployee Stock Option (right to buy) · Derivative 80,000 $0.00 Strike: $4.80 $0.00
Disclosure

SEC source: 0001415889-24-008543 · form4-03192024_040300.xml · derivative · entry 2

Hayes Christopher G. · CIK 0001805359 · CHIEF LEGAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires 2034-03-15

F2 · derivative.exercise_date: 25% of the total shares subject to the option shall vest on March 15, 2025 and 1/48th of the total shares subject to the option shall vest monthly thereafter over the remaining three years of the vesting period, subject to the Reporting Person's continuous service through such vesting date.

Read SEC document
March 15, 2024 Filed Mar 19, 2024 16:31 UTC
Hayes Christopher G.CHIEF LEGAL OFFICER
GrantCommon Stock 40,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-008543 · form4-03192024_040300.xml · nonDerivative · entry 1

Hayes Christopher G. · CIK 0001805359 · CHIEF LEGAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 163,226

F1 · shares: Represents a restricted stock unit ("RSU") award. The RSUs shall vest in equal annual installments on March 15, 2025, March 15, 2026, March 15, 2027 and March 15, 2028 subject to the Reporting Person's continuous service through each applicable date.

Read SEC document
March 15, 2024 Filed Mar 19, 2024 20:31 UTC
Goldenberg GaryCHIEF MEDICAL OFFICER
GrantEmployee Stock Option (right to buy) · Derivative 80,000 $0.00 Strike: $4.80 $0.00
Disclosure

SEC source: 0001415889-24-008542 · form4-03192024_040351.xml · derivative · entry 2

Goldenberg Gary · CIK 0001741938 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires 2034-03-15

F2 · derivative.exercise_date: 25% of the total shares subject to the option shall vest on March 15, 2025 and 1/48th of the total shares subject to the option shall vest monthly thereafter over the remaining three years of the vesting period, subject to the Reporting Person's continuous service through such vesting date.

Read SEC document
March 15, 2024 Filed Mar 19, 2024 20:31 UTC
Goldenberg GaryCHIEF MEDICAL OFFICER
GrantCommon Stock 40,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-008542 · form4-03192024_040351.xml · nonDerivative · entry 1

Goldenberg Gary · CIK 0001741938 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 126,257

F1 · shares: Represents a restricted stock unit ("RSU") award. The RSUs shall vest in equal annual installments on March 15, 2025, March 15, 2026, March 15, 2027 and March 15, 2028 subject to the Reporting Person's continuous service through each applicable date.

Read SEC document
March 15, 2024 Filed Mar 19, 2024 20:31 UTC
Bonaccorso JoeCHIEF COMMERCIAL OFFICER
GrantEmployee Stock Option (right to buy) · Derivative 80,000 $0.00 Strike: $4.80 $0.00
Disclosure

SEC source: 0001415889-24-008539 · form4-03192024_040347.xml · derivative · entry 2

Bonaccorso Joe · CIK 0001741973 · CHIEF COMMERCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires 2034-03-15

F2 · derivative.exercise_date: 25% of the total shares subject to the option shall vest on March 15, 2025 and 1/48th of the total shares subject to the option shall vest monthly thereafter over the remaining three years of the vesting period, subject to the Reporting Person's continuous service through such vesting date.

Read SEC document
March 15, 2024 Filed Mar 19, 2024 20:31 UTC
Bonaccorso JoeCHIEF COMMERCIAL OFFICER
GrantCommon Stock 40,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-008539 · form4-03192024_040347.xml · nonDerivative · entry 1

Bonaccorso Joe · CIK 0001741973 · CHIEF COMMERCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 132,392

F1 · shares: Represents a restricted stock unit ("RSU") award. The RSUs shall vest in equal annual installments on March 15, 2025, March 15, 2026, March 15, 2027 and March 15, 2028 subject to the Reporting Person's continuous service through each applicable date.

Read SEC document
March 15, 2024 Filed Mar 19, 2024 20:31 UTC
White TedDirector · PRESIDENT AND CEO
GrantEmployee Stock Option (right to buy) · Derivative 225,000 $0.00 Strike: $4.80 $0.00
Disclosure

SEC source: 0001415889-24-008538 · form4-03192024_040342.xml · derivative · entry 2

White Ted · CIK 0001741964 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 225,000

Underlying: Common Stock · 225,000 shares

Expires 2034-03-15

F2 · derivative.exercise_date: 25% of the total shares subject to the option shall vest on March 15, 2025 and 1/48th of the total shares subject to the option shall vest monthly thereafter over the remaining three years of the vesting period, subject to the Reporting Person's continuous service through such vesting date.

Read SEC document
March 15, 2024 Filed Mar 19, 2024 20:31 UTC
White TedDirector · PRESIDENT AND CEO
GrantCommon Stock 112,500 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-008538 · form4-03192024_040342.xml · nonDerivative · entry 1

White Ted · CIK 0001741964 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 282,590

F1 · shares: Represents a restricted stock unit ("RSU") award. The RSUs shall vest in equal annual installments on March 15, 2025, March 15, 2026, March 15, 2027 and March 15, 2028 subject to the Reporting Person's continuous service through each applicable date.

Read SEC document
December 29, 2023 Filed Dec 29, 2023 22:27 UTC PurchaseCommon Stock 115,774 $7.24 $838,203.76
Disclosure

SEC source: 0001062993-23-023292 · form4.xml · nonDerivative · entry 3

PERCEPTIVE ADVISORS LLC · CIK 0001224962 · 10% owner

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · 10% owner

EDELMAN JOSEPH · CIK 0001164426 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 7,099,182

F3 · price: The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.02 to $7.32 inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number shares purchased at each separate price within such range.

F4 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager of the Master Fund. Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.

Read SEC document
December 28, 2023 Filed Dec 29, 2023 22:27 UTC PurchaseCommon Stock 126,116 $7.08 $892,901.28
Disclosure

SEC source: 0001062993-23-023292 · form4.xml · nonDerivative · entry 2

PERCEPTIVE ADVISORS LLC · CIK 0001224962 · 10% owner

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · 10% owner

EDELMAN JOSEPH · CIK 0001164426 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 6,983,408

F2 · price: The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.76 to $7.30 inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number shares purchased at each separate price within such range.

F4 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager of the Master Fund. Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.

Read SEC document
December 27, 2023 Filed Dec 29, 2023 22:27 UTC PurchaseCommon Stock 79,726 $7.20 $574,027.20
Disclosure

SEC source: 0001062993-23-023292 · form4.xml · nonDerivative · entry 1

PERCEPTIVE ADVISORS LLC · CIK 0001224962 · 10% owner

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · 10% owner

EDELMAN JOSEPH · CIK 0001164426 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 6,857,292

F1 · price: The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.90 to $7.50 inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number shares purchased at each separate price within such range.

F4 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager of the Master Fund. Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.

Read SEC document
December 26, 2023 Filed Dec 27, 2023 00:21 UTC PurchaseCommon Stock 54,652 $6.49 $354,691.48
Disclosure

SEC source: 0000899243-23-020691 · doc4.xml · nonDerivative · entry 3

PERCEPTIVE ADVISORS LLC · CIK 0001224962 · 10% owner

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · 10% owner

EDELMAN JOSEPH · CIK 0001164426 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 6,777,566

F3 · price: The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.395 to $6.50 inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number shares purchased at each separate price within such range.

F4 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager of the Master Fund. Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.

Read SEC document
December 22, 2023 Filed Dec 27, 2023 00:21 UTC PurchaseCommon Stock 250,000 $6.67 $1,667,500.00
Disclosure

SEC source: 0000899243-23-020691 · doc4.xml · nonDerivative · entry 2

PERCEPTIVE ADVISORS LLC · CIK 0001224962 · 10% owner

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · 10% owner

EDELMAN JOSEPH · CIK 0001164426 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 6,722,914

F2 · price: The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.26 to $6.89 inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number shares purchased at each separate price within such range.

F4 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager of the Master Fund. Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.

Read SEC document
December 21, 2023 Filed Dec 27, 2023 00:21 UTC PurchaseCommon Stock 200,000 $6.17 $1,234,000.00
Disclosure

SEC source: 0000899243-23-020691 · doc4.xml · nonDerivative · entry 1

PERCEPTIVE ADVISORS LLC · CIK 0001224962 · 10% owner

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · 10% owner

EDELMAN JOSEPH · CIK 0001164426 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 6,472,914

F1 · price: The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.00 to $6.52 inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number shares purchased at each separate price within such range.

F4 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager of the Master Fund. Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.

Read SEC document
December 19, 2023 Filed Dec 19, 2023 22:52 UTC PurchaseCommon Stock 277,008 $5.36 $1,484,762.88
Disclosure

SEC source: 0001062993-23-022861 · form4.xml · nonDerivative · entry 3

PERCEPTIVE ADVISORS LLC · CIK 0001224962 · 10% owner

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · 10% owner

EDELMAN JOSEPH · CIK 0001164426 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 6,272,914

F3 · price: The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.065 to $5.60 inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number shares purchased at each separate price within such range.

F4 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager of the Master Fund. Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.

Read SEC document
December 18, 2023 Filed Dec 19, 2023 22:52 UTC PurchaseCommon Stock 456,923 $5.41 $2,471,953.43
Disclosure

SEC source: 0001062993-23-022861 · form4.xml · nonDerivative · entry 2

PERCEPTIVE ADVISORS LLC · CIK 0001224962 · 10% owner

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · 10% owner

EDELMAN JOSEPH · CIK 0001164426 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 5,995,906

F2 · price: The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.06 to $6.00 inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number shares purchased at each separate price within such range.

F4 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager of the Master Fund. Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.

Read SEC document
December 15, 2023 Filed Dec 19, 2023 22:52 UTC PurchaseCommon Stock 500,000 $5.97 $2,985,000.00
Disclosure

SEC source: 0001062993-23-022861 · form4.xml · nonDerivative · entry 1

PERCEPTIVE ADVISORS LLC · CIK 0001224962 · 10% owner

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · 10% owner

EDELMAN JOSEPH · CIK 0001164426 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 5,538,983

F1 · price: The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.3775 to $6.16 inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number shares purchased at each separate price within such range.

F4 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager of the Master Fund. Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.

Read SEC document
November 15, 2023 Filed Nov 16, 2023 21:34 UTC
Kohler TerryChief Financial Officer
SaleCommon Stock 9,632 $2.97 $28,607.04
Disclosure

SEC source: 0001209191-23-055531 · doc4.xml · nonDerivative · entry 2

Kohler Terry · CIK 0001872285 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,416

F1 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for RSUs that vested on August 24, 2023.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.95 to $3.00 inclusive.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.